Table 4 Means of each PIDAQ domain and the total PIDAQ score according to sex, age, orthodontic treatment worn, in the past or at the moment of the study and social class (CI 95%).
From: Factors related to the psychological impact of malocclusion in adolescents
Variable | PIDAQ DSC | PIDAQ SI | PIDAQ PI | PIDAQ AC | PIDAQ Total score |
|---|---|---|---|---|---|
Sex | |||||
Male n = 552 | 13.84 (13.42–14.25) | 3.36 (2.97–3.76) | 4.46 (4.13–4.80) | 1.89 (1.68–2.11) | 19.89 (18.90–20.87) |
Female n = 606 | 13.76 (13.29–14.23) | 3.75 (3.33–4.16) | 5.81 (5.41–6.21) | 2.33 (2.08–2.57) | 22.12 (20.90–23.33) |
P value | 0.816 | 0.191 | < 0.01** | 0.01* | < 0.01** |
Age | |||||
12 n = 627 | 13.26 (12.83–13.69) | 3.68 (3.29–4.06) | 4.95 (4.59–5.31) | 2.13 (1.91–2.36) | 21.50 (20.45–22.55) |
15 n = 531 | 14.43 (13.96–14.89) | 3.43 (3.00–3.86) | 5.43 (5.03–5.82) | 2.10 (1.87–2.34) | 20.53 (19.33–21.73) |
p value | < 0.01** | 0.396 | 0.08 | 0.857 | 0.232 |
Orthodontic treatment worn at the moment of the study | |||||
No n = 995 | 13.71 (13.36–14.05) | 3.49 (3.19–3.80) | 5.17 (4.88–5.50) | 2.10 (1.93–2.28) | 21.06 (20.21–21.91) |
Yes n = 163 | 14.35 (13.51–15.19) | 4.01 (3.19–4.83) | 5.13 (4.40–5.86) | 2.23 (1.76–2.69) | 21.02 (18.80–23.24) |
p value | 0.164 | 0.213 | 0.908 | 0.606 | 0.971 |
Orthodontic treatment previously worn | |||||
No n = 974 | 13.29 (12.94–13.63) | 3.71 (3.39–4.03) | 5.48 (5.18–5.78) | 2.22 (2.03–2.40) | 22.13 (21.25–23.00) |
Yes n = 184 | 16.49 (15.82–17.16) | 2.77 (2.16–3.38) | 3.50 (3.00–4.00) | 1.61 (1.26–1.96) | 15.39 (13.82–16.95) |
p value | < 0.01** | < 0.01** | < 0.01** | < 0.01** | < 0.01** |
Social class | |||||
High n = 440 | 13.97 (13.47–14.47) | 3.58 (3.10–4.05) | 5.14 (4.70–5.57) | 2.07 (1.81–2.34) | 20.82 (19.55–22.08) |
Middle n = 448 | 13.89 (13.37–14.41) | 3.23 (2.80–3.65) | 5.14 (4.72–5.57) | 2.01 (1.75–2.27) | 20.49 (19.21–21.77) |
Working n = 270 | 13.36 (12.71–14.01) | 4.10 (3.47–4.74) | 5.25 (4.70–5.81) | 2.38 (2.03–2.74) | 22.38 (20.70–24.06) |
p value | 0.318 | 0.071 | 0.943 | 0.216 | 0.183 |
Treatment need according to IOTN-DHC | |||||
No | 14.20 (13.86–14.55) | 3.30 (2.99–3.62) | 4.93 (4.64–5.22) | 2.02 (1.83–2.20) | 20.05 (19.19–20.92) |
Yes | 9.25 (8.25–10.25) | 5.17 (4.02–6.32) | 7.35 (6.33–8.37) | 2.81 (2.22–3.40) | 30.08 (27.18–32.98) |
p value | < 0.01** | < 0.01** | < 0.01** | < 0.01** | < 0.01** |
Treatment need according to IOTN-AC | |||||
No | 14.01 (13.67–14.35) | 3.35 (3.04–3.65) | 5.03 (4.74–5.31) | 2.05 (1.87–2.24) | 20.42 (19.58–21.26) |
Yes | 8.86 (7.50–10.24) | 5.80 (4.12–7.47) | 7.49 (5.98–9.01) | 2.86 (2.11–3.62) | 31.28 (26.77–35.80) |
p value | < 0.01** | < 0.01** | < 0.01** | 0.03* | < 0.01** |
Treatment need according to DAI | |||||
No | 14.59 (14.22–14.96) | 3.12 (2.80–3.44) | 4.69 (4.38–5.00) | 2.00 (1.80–2.20) | 19.22 (18.32–20.12) |
Yes | 12.39 (11.84–12.95) | 4.35 (3.80–4.90) | 6.01 (5.54–6.49) | 2.33 (2.05–2.61) | 24.84 (22.84–25.76) |
p value | < 0.01** | < 0.01** | 0.063 | < 0.01** | < 0.01** |
